内镜下静脉采集与开放静脉采集的经济学评价
该研究从英国国家卫生服务体系视角,采用马尔可夫模型评估冠状动脉旁路移植术中内镜下静脉采集与开放静脉采集的成本效果。结果显示,内镜下静脉采集每例患者终身可节省68.46英镑并获得0.206个质量调整生命年,净货币效益为6248.46英镑;在高危腿部伤口感染人群中净货币效益为7341.47英镑。概率敏感性分析显示,在每质量调整生命年3万英镑阈值下,内镜下静脉采集具有成本效果的概率为62.3%。
要点
- 内镜下静脉采集较开放采集每例节省68.46英镑并获0.206个质量调整生命年。
- 内镜下静脉采集为优势方案,净货币效益6248.46英镑。
- 高危腿部伤口感染人群中净货币效益为7341.47英镑。
核心结论
- 内镜下静脉采集是大隐静脉移植物采集的一种具有成本效果的方法。
- 需要超过5年随访的进一步临床数据来确认长期成本效果。
研究设计与样本
- 研究采用马尔可夫模型,从英国国家卫生服务体系视角评估内镜下静脉采集与开放静脉采集的成本效果,计算每获得一个质量调整生命年的终身增量成本。
- 通过范围文献综述为模型构建提供信息,并采用单因素和概率敏感性分析检验结果的稳健性。
主要发现
- 与开放静脉采集相比,内镜下静脉采集每例患者终身节省68.46英镑并获得0.206个质量调整生命年。
- 内镜下静脉采集为优势治疗方案,净货币效益为6248.46英镑。
- 在考虑腿部伤口感染高危人群的情景分析中,净货币效益为7341.47英镑。
- 概率敏感性分析显示,在每质量调整生命年3万英镑阈值下,内镜下静脉采集具有成本效果的概率为62.3%,凸显了随访事件率带来的不确定性。
局限性
- 概率敏感性分析显示内镜下静脉采集具有成本效果的概率为62.3%,凸显了随访事件率带来的不确定性。
- 需要超过5年随访的进一步临床数据来确认长期成本效果。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Endoscopic vein harvesting is an alternative to open vein harvesting during coronary artery bypass grafting. Although endoscopic vein harvesting includes significant clinical benefits, few long-term cost-effectiveness studies have been performed, limiting its use in the United Kingdom. In this study, we assessed the cost-effectiveness of endoscopic vein harvesting compared with open vein harvesting from the United Kingdom's National Health Service perspective. METHODS: A Markov model was developed to estimate the cost-effectiveness of endoscopic vein harvesting vs open vein harvesting by investigating the incremental lifetime costs per quality-adjusted life-year gained. A scoping literature review was conducted to inform the development of the model. One-way and probabilistic sensitivity analyses examined the robustness of the results. RESULTS: Compared with open vein harvesting, endoscopic vein harvesting leads to cost savings of £68.46 and quality-adjusted life-year gains of 0.206 per patient over a lifetime perspective. Thus, endoscopic vein harvesting is a dominant treatment option over open vein harvesting (net monetary benefit: £6248.46). In the scenario analysis, which accounted for a high-risk population with respect to leg wound infections, the net monetary benefit was £7341.47. The probabilistic sensitivity analysis showed that endoscopic vein harvesting has a 62.3% probability of being cost-effective at a threshold of £30,000 per quality-adjusted life-year, highlighting uncertainties resulting from follow-up event rates. CONCLUSIONS: Endoscopic vein harvesting is a cost-effective method of harvesting a saphenous vein graft. Further clinical data beyond 5 years of follow-up are required to confirm the long-term cost-effectiveness.
引用
- Eckey H, Heseler S, Hiligsmann M, et al. Economic Evaluation of Endoscopic vs Open Vein Harvesting. Ann Thorac Surg. 2022. PMID: 37096651. doi:10.1016/j.athoracsur.2022.09.017
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。